Thus CD34+ AML cells demonstrated increased reductive metabolites (i.e., reductive stress) compared to normal PBMCs and brusatol treatment decreased aberrant reductive metabolite levels to baseline (GSH/GSSG ratio). Here, CD34 is linked to acute myeloid leukemia.